International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7847891
Original Article
Prospective Study on the Clinico-Hematological Profile of Dengue Fever Patients in Hims, Hassan
 ,
 ,
 ,
Published
April 20, 2023
Abstract
Introduction: Dengue virus causes a spectrum of illness ranging from in apparent, self-limiting classical dengue fever (DF) to life threatening dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS). Present study is done to identify the clinical profile, hematological profile and disease outcome in dengue fever cases. Methods: A total of120 cases aging 18 to 80 years diagnosed as dengue fever based on rapid immunological card test (Ns1 antigen, IgG and IgM antibodies) were analysed for clinical and hematological parameters. A prospective observational study was conducted at HIMS, Hassan. Result: During the study period, a total of 120 dengue cases were included in the study. Of these61%male, 39%female.NS1 antigen positive 35(29%), IGM 50%positive was being highest and IGG 21%.The most common presentation was fever (100%) followed by myalgia (75%),retro orbital pain and vomiting (33%).The common hematological finding was thrombocytopenia 81(67.5%),followed by anemia66(55%), leucopenia39(39%) and the elevated levels of AST and ALT was noted. Conclusion: Thrombocytopenia, leucopenia, elevated AST and ALT gives clues to test dengue fever so that the dengue cases can be identified in early stages and prompt management can be started to prevent complications.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2844 Views
142 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved